Roivant Sciences ROIV
NASDAQ ROIV
$37.45 +0.65 (+1.77%)
At close: Oct 22, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Non Operating Income (2021 - 2022)

Updated

Roivant Sciences' Non Operating Income was $18.1 million in fiscal Q3 2023 (quarter ended Dec 31, 2022), up 634.4% from $2.46 million a year earlier.

Analysis

Roivant Sciences (ROIV) Non Operating Income (2021 - 2022) Analysis & Trends

On a trailing twelve-month basis, Roivant Sciences' Non Operating Income was $12.41 million through Dec 31, 2022.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 387.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Roivant Sciences 27.06 Bn 10.70 Bn 1.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 18.10 Mn
Sep 30, 2022 -5.95 Mn
Dec 31, 2021 2.46 Mn
Sep 30, 2021 -2.20 Mn
API Access

Roivant Sciences Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ROIV&period=max&api_key=YOUR_API_KEY